(1RS,13SR,14RS)-1-HEXYL-4,7,10-TRIAZA-1-AZONIATETRACYCLO-[5.5.2.0.(4,14)0.(10,13)]-TETRADECANE-IODIDE
Compound with spectra: 1 NMR
![(1RS,13SR,14RS)-1-HEXYL-4,7,10-TRIAZA-1-AZONIATETRACYCLO-[5.5.2.0.(4,14)0.(10,13)]-TETRADECANE-IODIDE](/api/compound/aqrPVCXDeV.png?ph=true&h=300&w=458 "(1RS,13SR,14RS)-1-HEXYL-4,7,10-TRIAZA-1-AZONIATETRACYCLO-[5.5.2.0.(4,14)0.(10,13)]-TETRADECANE-IODIDE")
| SpectraBase Compound ID | aqrPVCXDeV |
|---|---|
| InChI | InChI=1S/C16H31N4.HI/c1-2-3-4-5-12-20-13-10-18-7-6-17-8-9-19(11-14-20)16(20)15(17)18;/h15-16H,2-14H2,1H3;1H/q+1;/p-1 |
| InChIKey | RXEDHFRBJKTRPA-UHFFFAOYSA-M |
| Mol Weight | 406.36 g/mol |
| Molecular Formula | C16H31IN4 |
| Exact Mass | 406.159342 g/mol |
| Parent InChIKey | JZUFYSOVZDHIHH-UHFFFAOYSA-M |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1RS,13SR,14RS)-1-DECYL-4,7,10-TRIAZA-1-AZONIATETRACYCLO-[5.5.2.0.(4,14)0.(10,13)]-TETRADECANE-IODIDE
(1RS,13SR,14RS)-1-TETRADECYL-4,7,10-TRIAZA-1-AZONIATETRACYCLO-[5.5.2.0.(4,14)0.(10,13)]-TETRADECANE-IODIDE
(1RS,13SR,14RS)-1-HEXADECYL-4,7,10-TRIAZA-1-AZONIATETRACYCLO-[5.5.2.0.(4,14)0.(10,13)]-TETRADECANE-IODIDE
(1RS,13SR,14RS)-1-PENTYL-4,7,10-TRIAZA-1-AZONIATETRACYCLO-[5.5.2.0.(4,14)0.(10,13)]-TETRADECANE-IODIDE
(1RS,13SR,14RS)-1-BUTYL-4,7,10-TRIAZA-1-AZONIATETRACYCLO-[5.5.2.0.(4,14)0.(10,13)]-TETRADECANE-IODIDE
Hexaallylhexaazaisowurtzitane
trans-1-Methyl-2,3-bis(1-pyrrolidinyl)-1,2,3,4-tetrahydropyridine-5-carbonitrile
(1R*,3S*,4aS*,4bS*,6S*,8R*)-1,3,6,8-tetramethylperhydro-4,5,8a,9a-tetraazafluorene
(1R*,3S*,4AS*,4BS*,6R*,8S*)-1,3,6,8-TETRAMETHYLPERHYDRO-4,5,8A,9A-TETRAAZAFLUORENE
4-[3-(5-Methoxy-1,2,3,4-tetrahydronaphthlen-1-yl)-n-propyl]-1-(2-pyridyl)piperazine
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of Lipophilic Paramagnetic Contrast Agents | The Journal of Organic Chemistry | 1999 |